Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

9 results
Display

Reply on “Vitamin D and coronary atherosclerosis”

Lee AY, Kim JK, Kang JH, Yu BY, Kim SJ

  • Osteoporos Sarcopenia.
  • 2017 Dec;3(4):202-202.
  • doi: 10.1016/j.afos.2017.11.004
No abstract available.
Vitamin D and coronary atherosclerosis

Kim DJ

  • Osteoporos Sarcopenia.
  • 2017 Dec;3(4):201-201.
  • doi: 10.1016/j.afos.2017.11.003
No abstract available.
Sarcopenia in elderly patients with chronic low back pain

Sakai Y, Matsui H, Ito S, Hida T, Ito K, Koshimizu , Harada A

  • Osteoporos Sarcopenia.
  • 2017 Dec;3(4):195-200.
  • doi: 10.1016/j.afos.2017.09.001
OBJECTIVES: The prevalence of chronic low back pain (CLBP) increases with age and several mechanisms are involved in the development of CLBP, including osteoporosis; however, no associations with sarcopenia have...
Is osteoporosis a risk factor for ankle fracture?: Comparison of bone mineral density between ankle fracture and control groups

Lee DO, Kim JH, Yoo BC, Yoo JH

  • Osteoporos Sarcopenia.
  • 2017 Dec;3(4):192-194.
  • doi: 10.1016/j.afos.2017.11.005
OBJECTIVES: There remains controversy over osteoporotic feature of the ankle. Therefore, we investigated the possibility of the existence of a relationship between axial bone mineral density (BMD) in patients with...
Effects of combined therapy of alendronate and low-intensity pulsed ultrasound on metaphyseal bone repair after osteotomy in the proximal tibia of glucocorticoid-induced osteopenia rats

Kawano T, Miyakoshi , Kasukawa Y, Hongo M, Tsuchie H, Sato C, Fujii M, Suzuki M, Akagawa M, Ono Y, Yuasa Y, Nagahata I, Shimada Y

  • Osteoporos Sarcopenia.
  • 2017 Dec;3(4):185-191.
  • doi: 10.1016/j.afos.2017.11.001
OBJECTIVES: Glucocorticoid (GC) treatment inhibits activation of runt-related transcription factor 2 (Runx2), which is essential for osteoblast differentiation from stem cells. As a result, GC treatment results in bone loss,...
Understanding the factors associated with initiation and adherence of osteoporosis medication in Japan: An analysis of patient perceptions

Orimo H, Sato M, Kimura S, Wada K, Chen X, Yoshida S, Crawford B

  • Osteoporos Sarcopenia.
  • 2017 Dec;3(4):174-184.
  • doi: 10.1016/j.afos.2017.10.002
OBJECTIVES: This study aimed to identify factors associated with initiation and adherence of osteoporosis medication from a patient perspective. METHODS: A web-based survey was developed based on health behavior theories. Descriptive...
Calcemic response to burns differs between adults and children: A review of the literature

Klein GL, Benjamin D, Herndon DN

  • Osteoporos Sarcopenia.
  • 2017 Dec;3(4):170-173.
  • doi: 10.1016/j.afos.2017.10.001
OBJECTIVES: The calcemic and parathyroid hormone (PTH) responses to severe burn injury appear to differ between children and adults. In our limited studies children exhibited hypocalcemic hypoparathyroidism consistent with up-regulation...
Surgical treatment of severe osteoporosis including new concept of advanced severe osteoporosis

Kim JH, Park YS, Oh KJ, Choi HS

  • Osteoporos Sarcopenia.
  • 2017 Dec;3(4):164-169.
  • doi: 10.1016/j.afos.2017.11.006
Severe osteoporosis is classified as those with a bone mineral density (BMD) T-score of −2.5 or lower, and demonstrate one or more of osteoporotic, low-trauma, fragility fractures. According to the...
The Asian Federation of Osteoporosis Societies' call to action to improve the undertreatment of osteoporosis in Asia

Yeap SS, Jaisamrarn U, Park YS, Takeuchi Y, Xia W

  • Osteoporos Sarcopenia.
  • 2017 Dec;3(4):161-163.
  • doi: 10.1016/j.afos.2017.11.002
No abstract available.

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr